✦ Where quality meets affordability · Biomed-tested · Certified

Abbott’s paravalvular leak treatment secures FDA approval

Abbott’s paravalvular leak treatment secures FDA approval
Summary

Abbott’s Amplatzer Paraclose Occluder is designed to mitigate the need for revision surgery in cases where gaps form around a replacement heart valve.

The post Abbott’s paravalvular leak treatment secures FDA approval appeared first on Medical Device Network.

Read the full article ↗Looking to buy or rent? Get a quote

More from Medical Device Network

Dexcom lifts 2026 revenue outlook after positive Q3Omron Healthcare begins production at first India plantJ&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3Baxter’s shares fall as Q3 probability dips despite revenue growth